Coronavirus vaccine distribution expected to start in mid-2021: WHO

The large-scale global distribution of vaccines against Covid-19 is not expected until mid-2021, the WHO chief scientist Dr Soumya Swaminathan told a press briefing on Friday

covid-19, vaccine, coronavirus
Representative image
ANI US
1 min read Last Updated : Sep 05 2020 | 8:32 AM IST

The large-scale global distribution of vaccines against COVID-19 is not expected until mid-2021, the World Health Organization's (WHO) chief scientist Dr Soumya Swaminathan told a press briefing on Friday.

"So realistically speaking, probably the second half, the middle of 2021 - maybe the second quarter, the third quarter of 2021 - is when we can start seeing doses actually flowing into countries so that they can start to immunize their populations," Swaminathan said

This timeline is based on the fact that Phase 3 trials of many candidate vaccines are not expected to be concluded until the end of the current year, the WHO's chief scientist added.

"We expect results from some of the candidates, which are already in Phase 3 trials, to come by the end of the year or beginning of next year, following which they'll have to be scaling [up] manufacturing to produce the hundreds of millions of doses that are going to be needed. In fact, the world is going to need billions of doses, and that is going to take time to manufacture. So we have to be optimistic and realistic at the same time," Swaminathan commented.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusWorld Health OrganisationCoronavirus Vaccine

First Published: Sep 05 2020 | 8:20 AM IST

Next Story